Carboxamide compound

TW202639536APending Publication Date: 2026-10-01UBE CORPORATION

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: TW114129833
Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2025-02-05
Filing Date: 2025-08-05
Publication Date: 2026-10-01

Application Information

Patent Timeline

05 Feb 2025

Priority

05 Aug 2025

Application

TW114129833

01 Oct 2026

Publication

TW202639536A

IPC: C07D403/04; A61K31/397; A61K31/40; A61K31/4178; A61K31/4427; A61K31/444; A61K31/445; A61K31/497; A61K31/501; A61K31/506; A61K31/541; A61P29/00; A61P43/00; C07D205/04; C07D207/04; C07D401/12; C07D401/14; C07D405/04; C07D409/04; C07D417/14

Inventors: 小森健一; 小川雄大

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

An object of the present invention is to provide a compound having an LPA receptor antagonistic action and a pharmaceutical composition containing the same. Specifically, the present invention provides a compound represented by the following general formula (I): or a deuterated form thereof, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same, wherein the symbols have the meanings described in the specification.

Need to check novelty before this filing date? Find Prior Art

Explore free tools for quick IP tasks

Patent Information

Abstract